Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

Counterfeit and substandard antimalarial drugs in Cambodia.

Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, Blum N, Christophel EM, Smine A.

Trans R Soc Trop Med Hyg. 2006 Nov;100(11):1019-24.

PMID:
16765399
2.

Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.

Vijaykadga S, Cholpol S, Sitthimongkol S, Pawaphutanan A, Pinyoratanachot A, Rojanawatsirivet C, Kovithvattanapong R, Thimasarn K.

Southeast Asian J Trop Med Public Health. 2006;37 Suppl 3:5-10.

PMID:
17547041
3.

Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.

Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, McGready R, Farrar JJ, Looareesuwan S, Day NP, Green MD, White NJ.

Trop Med Int Health. 2004 Dec;9(12):1241-6.

6.

Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia.

Khan MH, Okumura J, Sovannarith T, Nivanna N, Akazawa M, Kimura K.

Trop Med Int Health. 2010 May;15(5):639-44. doi: 10.1111/j.1365-3156.2010.02494.x.

7.

Characterization of counterfeit artesunate antimalarial tablets from southeast Asia.

Hall KA, Newton PN, Green MD, De Veij M, Vandenabeele P, Pizzanelli D, Mayxay M, Dondorp A, Fernandez FM.

Am J Trop Med Hyg. 2006 Nov;75(5):804-11.

8.

Use and quality of antimalarial drugs in the private sector in Viet Nam.

Cong LD, Yen PT, Nhu TV, Binh LN.

Bull World Health Organ. 1998;76 Suppl 1:51-8.

9.

Pilot study of essential drug quality in two major cities in India.

Bate R, Tren R, Mooney L, Hess K, Mitra B, Debroy B, Attaran A.

PLoS One. 2009 Jun 23;4(6):e6003. doi: 10.1371/journal.pone.0006003.

10.

Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.

Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, Socheat D, Ariey F, Wongsrichanalai C.

Malar J. 2009 Jan 12;8:10. doi: 10.1186/1475-2875-8-10.

11.

Counterfeit pharmaceuticals: current status and future projections.

Wertheimer AI, Chaney NM, Santella T.

J Am Pharm Assoc (2003). 2003 Nov-Dec;43(6):710-7; quiz 717-8.

PMID:
14717268
12.

Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure.

Hodel EM, Genton B, Zanolari B, Mercier T, Duong S, Beck HP, Olliaro P, Decosterd LA, Ariey F.

J Infect Dis. 2010 Oct 1;202(7):1088-94. doi: 10.1086/655779.

PMID:
20726764
13.

Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.

Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F.

Malar J. 2009 Jan 12;8:11. doi: 10.1186/1475-2875-8-11.

14.

Fake artesunate in southeast Asia.

Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, Chotivanich K, Mayxay M, Looareesuwan S, Farrar J, Nosten F, White NJ.

Lancet. 2001 Jun 16;357(9272):1948-50.

PMID:
11425421
15.

Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.

Nayyar GM, Breman JG, Newton PN, Herrington J.

Lancet Infect Dis. 2012 Jun;12(6):488-96. doi: 10.1016/S1473-3099(12)70064-6. Review. Erratum in: Lancet Infect Dis. 2012 Jul;12(7):506.

PMID:
22632187
16.

Antimalarial drug resistance and the importance of drug quality monitoring.

Green MD.

J Postgrad Med. 2006 Oct-Dec;52(4):288-90. Review.

17.

Detecting counterfeit antimalarial tablets by near-infrared spectroscopy.

Dowell FE, Maghirang EB, Fernandez FM, Newton PN, Green MD.

J Pharm Biomed Anal. 2008 Nov 4;48(3):1011-4. doi: 10.1016/j.jpba.2008.06.024.

PMID:
18703302
18.

Mekong malaria. II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia.

Socheat D, Denis MB, Fandeur T, Zhang Z, Yang H, Xu J, Zhou X, Phompida S, Phetsouvanh R, Lwin S, Lin K, Win T, Than SW, Htut Y, Prajakwong S, Rojanawatsirivet C, Tipmontree R, Vijaykadga S, Konchom S, Cong le D, Thien NT, Thuan le K, Ringwald P, Schapira A, Christophel E, Palmer K, Arbani PR, Prasittisuk C, Rastogi R, Monti F, Urbani C, Tsuyuoka R, Hoyer S, Otega L, Thimasarn K, Songcharoen S, Meert JP, Gay F, Crissman L, Cho-Min-Naing, Chansuda W, Darasri D, Indaratna K, Singhasivanon P, Chuprapawan S, Looareesuwan S, Supavej S, Kidson C, Baimai V, Yimsamran S, Buchachart K.

Southeast Asian J Trop Med Public Health. 2003;34 Suppl 4:1-102.

PMID:
15906747
19.

Factors contributing to antimalarial drug resistance in Rachuonyo district, Kenya.

Angira CH, Otieno OA, Muga RO, Abong'o BO.

East Afr J Public Health. 2010 Mar;7(1):11-5.

PMID:
21413566
20.

Interventions to improve the use of antimalarials in south-east Asia: an overview.

Gomes M, Wayling S, Pang L.

Bull World Health Organ. 1998;76 Suppl 1:9-19.

Supplemental Content

Support Center